Evidence map›Paper›PMID 36503439›Full record

ArticleHarm reduction journal2022

Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study.

Katy Holloway, Shannon Murray, Marian Buhociu, Alisha Arthur, Rondine Molinaro, Sian Chicken, Elwyn Thomas, Sam Courtney, Alan Spencer, Rachel Wood and 3 more

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Katy HollowayUniversity of South Wales, Caerleon, Wales. katy.holloway@southwales.ac.uk.
Shannon MurrayUniversity of South Wales, Caerleon, Wales.
Marian BuhociuUniversity of South Wales, Caerleon, Wales.
Alisha ArthurUniversity of South Wales, Caerleon, Wales.
Rondine MolinaroUniversity of South Wales, Caerleon, Wales.
Sian ChickenUniversity of South Wales, Caerleon, Wales.
Elwyn ThomasUniversity of South Wales, Caerleon, Wales.
Sam CourtneyUniversity of South Wales, Caerleon, Wales.
Alan SpencerUniversity of South Wales, Caerleon, Wales.
Rachel WoodUniversity of South Wales, Caerleon, Wales.
Ryan ReesUniversity of South Wales, Caerleon, Wales.
Stephen WalderUniversity of South Wales, Caerleon, Wales.
Jessica StaitUniversity of South Wales, Caerleon, Wales.
University of South Wales · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe measures implemented to contain the spread of the COVID-19 virus disrupted the provision of substance misuse treatment and support. However, little is known about the impact of this disruption on individuals seeking treatment for drug- and/or alcohol-related problems (henceforth service users). This study aimed to help substance misuse services learn lessons and identify ways of optimising delivery and minimising harm in the event of any future lockdowns or global crises.

methodsThe study was co-produced by a team of peer researchers, practitioners, policymakers and academics. Telephone interviews were conducted with 202 substance misuse service users over a 6-month period commencing June 2020. The interviews were conducted by a small group of seven peer researchers each with lived experience of substance use problems. The interview data were recorded by the peers in an anonymous online questionnaire survey and analysed using standard quantitative and qualitative methods.

resultsService users responded to the COVID-19 pandemic in a variety of ways. Diverse responses were noted in relation to their substance use patterns, their personal lives and their substance misuse treatment experiences. For some, the pandemic acted as a new risk environment factor that increased their vulnerability to substance-related harm. For others, it facilitated aspects of the enabling environment, thereby reducing the risk of harm.

conclusionsService users are not a homogenous group, and an individualised approach to treatment that recognises the potential for varied responses to the same stimuli is needed. The findings suggest that service users would benefit from having a choice in how they access treatment and from greater access to outreach programmes that take treatments and harm reduction tools such as naloxone into the community. The research also supports the involvement of people with lived experience in substance use research, policy and practice.

Indexed as

COVID-19Drug UsersSubstance-Related DisordersCommunicable Disease ControlHumansPandemics

Identifiers

PMID36503439
PMCPMC9742020
OpenAlexW4311125284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.